Published On: 3/18/2020
COVID-19 Response
Based on the current recommendations from the CDC and Governor of North Carolina, the entire TARGET PharmaSolutions staff has transitioned to a remote working environment. During this time, TARGET expects work to continue as usual.
TARGET shares its support to all of those who have been affected by the expanding global corona virus, or COVID-19, outbreak.
Stay up-to-date on the virus from the World Health Organization (WHO): https://www.who.int/emergencies/diseases/novel-coronavirus-2019
About Target RWE
As the industry's best-in-class, complete real world evidence (RWE) solution, Target RWE is a distinctly collaborative enterprise that unifies real world data (RWD) sets and advanced RWE analytics in an integrated community, shifting the paradigm in healthcare for how decisions are made to improve lives.
Target RWE sources unique, connected data sets across multiple therapeutic areas representing granular data from diverse patients in academic and community settings. Our rigorous, interactive, and advanced RWE analytics extract deep insights from RWD to answer important questions in healthcare. Target RWE brings together the brightest minds in healthcare through an unmatched community of key opinion leaders, patients, and healthcare stakeholders in a collaborative and dynamic model. www.targetrwe.com
Contact:
Kayla Slake
Marketing Manager
984.234.0268 ext 205
More News
-
01/11/2023
Target RWE Launches 35 New Disease State Registries in Complex Indications with High Unmet Medical Needs and Rapidly Evolving Therapies -
11/04/2022
New TARGET-NASH Real World Data Show Non-Alcoholic Fatty Liver Disease Severity and Gender Linked to Disparities in Polypharmacy -
10/18/2022
Target RWE and the American Association for the Study of Liver Diseases Announce Research Agreement for Cirrhosis Quality Collaborative -
08/25/2022
New Approaches for Developing Real-World Evidence Presented by Target RWE at the 2022 International Conference on Pharmacoepidemiology (ICPE) -
08/24/2022
Durham-Based Target RWE Grows Data Abstraction, Curation Capabilities with Latest Acquisition